ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 063,79
-0,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Nkarta Inc (NKTX) Cours

Nkarta Inc

Nkarta Inc (NKTX)

NASDAQ
1,66
-0,06
(-3,49%)
Fermé 16 Mars 9:00PM
Retardé de 15 minutes
1,71
0,05
(3,01%)
Après les heures de négociation: 9:58PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,71
Prix Achat
1,67
Prix Vente
1,70
Volume échangé
1 190 986
1,65 Fourchette du Jour 1,745
1,57 Plage de 52 semaines 13,90
Cap du marché
120,673M
Clôture Veille
1,72
Ouverture
1,74
Dernière Transaction
6
@
1.6996
Dernière heure de transaction
Volume financier
US$ 2 010 813
VWAP
1,6884
Volume moyen (3 m)
1 072 659
Actions en circulation
70 568 754
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,00
Bénéfice par action (BPA)
-1,67
Chiffre d'affairess
-
Bénéfice net
-117,5M

À propos de Nkarta Inc

Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and d... Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. It is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The company's operations are based in South San Francisco, California and it operates in one segment. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Nkarta Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker NKTX. Le dernier cours de clôture d'Nkarta était de US$1,72. Au cours de la dernière année, les actions de Nkarta ont été négociées dans une fourchette de prix de US$ 1,57 à US$ 13,90.

Nkarta compte actuellement 70 568 754 actions en circulation. La capitalisation boursière d'Nkarta est de US$121,38 million. Nkarta a un ratio cours/bénéfice (ratio PE) de -1.00.

NKTX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
17 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
17 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
17 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Janvier 2025
NKTX (-3,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Janvier 2025
NKTX (-3,49%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1325-7.191316146541.84251.951.666520231.80225749CS
4-0.42-19.71830985922.132.351.579959371.89320793CS
12-0.475-21.73913043482.1852.71.5710726592.21916695CS
26-4.01-70.10489510495.725.881.5711632002.68775899CS
52-11.04-86.588235294112.7513.91.579954114.6958606CS
156-8.18-82.70980788689.8920.351.2811881308.3137882CS
260-53.04-96.876712328854.7579.161.2885056910.62799824CS

NKTX - Frequently Asked Questions (FAQ)

What is the current Nkarta share price?
The current share price of Nkarta is US$ 1,71
How many Nkarta shares are in issue?
Nkarta has 70 568 754 shares in issue
What is the market cap of Nkarta?
The market capitalisation of Nkarta is USD 121,38M
What is the 1 year trading range for Nkarta share price?
Nkarta has traded in the range of US$ 1,57 to US$ 13,90 during the past year
What is the PE ratio of Nkarta?
The price to earnings ratio of Nkarta is -1
What is the reporting currency for Nkarta?
Nkarta reports financial results in USD
What is the latest annual profit for Nkarta?
The latest annual profit of Nkarta is USD -117,5M
What is the registered address of Nkarta?
The registered address for Nkarta is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Nkarta operate in?
Nkarta operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NKTX
Nkarta
COIN
ELYUSD
Elycoin
USOTC
CFRLF
China Aircraft Leasing (PK)
NYSE
ATCO-I
Atlas
LSE
KGI
TG
8TC
BlackRock TCP Capital
UNSW
ECLETH
Eclipseum
TSX
ZCB
BMO Corporate Bond Index...
NASDAQ
UBSI
United Bankshares
TG
CHSR
UBS Global Asset Managem...
TG
DF3
BowFlex
USOTC
TNGCF
Tongcheng Travel (PK)
USOTC
FUGRF
Fugro Nv (PK)
USOTC
MNII
Manati Inds (CE)
NASDAQ
CRWS
Crown Crafts
USOTC
GALMF
Galileo Mining (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces